← Back to Search

Back and forth pattern for Wound Infection

N/A
Recruiting
Led By Sean P Cronin, MD
Research Sponsored by Albert Einstein Healthcare Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BMI >30
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-4 days
Awards & highlights

Study Summary

This trial will help establish if there is an optimal pattern to apply ChloraPrep prior to cesarean deliveries in obese patients in order to decrease the rate of infection.

Eligible Conditions
  • Wound Infection
  • Cesarean Section Complications

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have a body mass index (BMI) higher than 30, which means you are considered obese.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-4 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-4 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Skin bacterial burden
Secondary outcome measures
Hospital Re-admissions
Surgical site infection

Trial Design

2Treatment groups
Active Control
Group I: Back and forth patternActive Control1 Intervention
Abdominal skin prep using ChloraPrep 2 x 26 mL single use applicators. The first applicator will be applied to the skin prep over the suspected skin incision site for 30 sec - the first applicator will then be used in a back and forth pattern work up towards the upper edge of the surgical field. The first applicator will then be discarded. The second applicator will then again start at the expected site of the incision and again working inferiority until the lower edge of the surgical field is reached.
Group II: Circular patternActive Control1 Intervention
Abdominal skin prep using ChloraPrep 2 x 26 mL single use applicators. The first applicator will be applied to the skin over the suspected skin incision site for 30 sec - the applicator will then be moved in a circular pattern moving outwards form the incision site until approximately half of thee surgical field is cleaned. The second applicator will then be used to complete the surgical prep until the entire surgical field is prepped in accordance with the package instructions.

Find a Location

Who is running the clinical trial?

Albert Einstein Healthcare NetworkLead Sponsor
63 Previous Clinical Trials
868,522 Total Patients Enrolled
Sean P Cronin, MDPrincipal InvestigatorAlbert Einstein Healthcare Network
Megan E Piacquadio, DOPrincipal InvestigatorAlbert Einstein Healthcare Network

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~24 spots leftby Mar 2025